Potential risks of eliciting antibodies enhancing HIV-1 infection of monocytic cells by vaccination with V3 loops of unmatched HIV-1 isolates

AIDS. 1992 Mar;6(3):331-2. doi: 10.1097/00002030-199203000-00013.
No abstract available

Publication types

  • Letter

MeSH terms

  • AIDS Vaccines / adverse effects*
  • HIV Antibodies / adverse effects*
  • HIV Envelope Protein gp120 / immunology*
  • HIV Infections / immunology
  • HIV-1 / immunology*
  • HIV-1 / physiology
  • Humans
  • Macrophages / immunology
  • Macrophages / microbiology
  • Monocytes / immunology
  • Monocytes / microbiology
  • Peptide Fragments / immunology*
  • Vaccines, Synthetic / adverse effects*

Substances

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments
  • Vaccines, Synthetic